Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
July 13, 2020 11:03 am ETEstimated Read Time: 3 Minutes
Cannabis laws continue to evolve rapidly across the country, even in the midst of the Covid-19 crisis and the achievements of the Black Lives Matter movement. Most recently, the state of Iowa passed a bill expanding the availability and accessibility of medical cannabis for Iowans. The bill passed Wednesday, June 3rd, the first day back in session for the Iowa Senate after having been in recess for several weeks due to Covid-19. Having passed the Senate, the bill was signed into law by Iowa Governor Kim Reynolds.
The History of the Bill
The passage of this bill has been hotly contested for some time. In its original iteration, written in 2019, the bill offered a cap of 25 grams of THC over 90 days, meaning that that was the maximum amount of THC that could be contained in any cannabis-based medical product purchased over a 90 day period.
Many lawmakers felt that the 25-gram cutoff was too high. Because several cannabis-based medical treatments focus on the use of cannabidiol, or CBD, as opposed to THC, those lawmakers had a leg to stand on. Many states have made their first steps toward legalization by focusing on CBD, a substance which is non-psychoactive in nature.
Although the first version of the bill did pass the Senate vote, it was vetoed by the Governor and returned to the senate to be redrafted.
What Does the New Bill Contain?
The new version of the bill is similar in nature to the old one, but with one very significant difference. The THC cap has been adjusted to 4.5 grams. Though significantly lower than what was originally proposed, this is still an increase over what Iowa has previously allowed.
The bill also expands parameters for who will be able to access medical cannabis. Under the new legislation, those suffering from post-traumatic stress disorder and autism involving self-harm will be eligible to take advantage of medical cannabis programs.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
The bill also provides the opportunity for physicians to order higher doses of THC in extreme or unusual cases.
Iowa Citizens Respond
We have yet to see how Iowans as a whole will respond to the bill, but the sentiment among the senators was mixed. The bill passed with a 32-17 majority—significant, but hardly unanimous.
Those who stood in opposition to the bill maintained that more research still needed to be done on the benefits, effects, and potential uses of CBD. That’s a sentiment many agree with, and as legalization continues to spread, the opportunities for quality research are certain to spread as well. The passage of this bill is one step forward in enabling medical researchers to get their hands on cannabis, conduct and publish studies, and make the discoveries that will benefit all of us.
Those who supported the bill mentioned the importance of making cannabis-based treatments available to Iowans who were suffering, although they were quick to point out grievances as well. Some felt that the THC cap was too strict, that it would stop people from getting the help they needed.
Others were concerned that the bill carried the potential for discrimination against racial minorities and the economically disadvantaged. Drug laws have historically punished these groups disproportionately, and some Iowan lawmakers felt that Governor Reynolds wasn’t taking that aspect of the bill into consideration.
Iowa has made a stride forward with this bill. It remains to be seen how Iowan legislation will evolve from here, and which states will follow in their footsteps.
Kat Helgeson comes from a ten year career in social media marketing and content creation. She takes pride in her ability to communicate the culture and values of an organization via the written word. Kat is also the author of numerous books for young adults. Her titles have received the Junior Library Guild Award, the Bank Street College of Education Best Books of the Year Distinction, and been featured on the Illinois Reads selection list. Her work has been translated into Dutch and German.
Blunts: What are they exactly, and how do they affect your body? If you’re interested in smoking blunts—or already smoke them—this guide is for you. We’ll cover everything you need to know about this popular cannabis intake method, including how they’re made, how they differ from spliffs and joints, risks of use, and alternative intake…
“Stoned,” “high,” “tripping,” and “baked,” are all terms engrained in the cannabis community. These metaphorical descriptions contribute to how we perceive, interpret, and learn from the experiences produced by cannabis consumption. Cannabis experiences, of course, are unique and highly variable. Specific plant strains, the presence of other cannabinoids, different delivery methods, and a user’s individual…
Thanks to the growing wave of legalization, more consumers than ever can grow their own cannabis right at home. Growing essentials that used to be secretive are now bought and sold freely. This includes items, like grow tents, nutrients, LED lighting, HPS lighting, ventilation, and more. Keeping all these items straight is hard enough, but…
Skin diseases plague millions of individuals, inflicting both physical discomforts in addition to mental and social stress. Thankfully, there is no shortage of skin treatment options available on the market. That said, this established market may soon be in for a major shake-up if recent cannabis research is any indication. Traditionally, cannabis research focused on studying…
As more states move toward legalization, accurately detecting impaired driving is of the utmost importance. Field Sobriety Tests (FSTs) have long been the go-to method for law enforcement to assess driver impairment caused by substances like alcohol. However, a recent 2023 study published in JAMA Psychiatry raises serious questions about the accuracy of these tests…
We use our own as well as third party cookies to improve your site experience and the services we make available. You can learn more about our use of cookies in our Privacy Policy.
Content Disclamer
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.